AstraZeneca Inks Deal with Nektar
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 10 (Table of Contents)
Published: 1 Oct-2009
DOI: 10.3833/pdr.v2009.i10.1251 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
AstraZeneca has signed a licensing deal with Nektar Therapeutics to develop and market the latter’s two drugs, NKTR-118 and NKTR-119, for the treatment of constipation, a common side effect of opioid painkillers...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS